VEGF can attenuate the antitumor immune response by reprogramming the tumor immune microenvironment; thus, anti-VEGF combined with immunotherapy has a potential synergistic antitumor effect (Bejarano et al., 2021). This evidence concerns the gene VEGFA and neoplasm.